标题
Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 14, Pages 5036
出版商
MDPI AG
发表日期
2020-07-17
DOI
10.3390/ijms21145036
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer
- (2020) Konrad H. Stopsack et al. CLINICAL CANCER RESEARCH
- Rare germline genetic variants and risk of aggressive prostate cancer
- (2020) Tú Nguyen‐Dumont et al. INTERNATIONAL JOURNAL OF CANCER
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
- (2020) Tommi Rantapero et al. Genes
- Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology
- (2020) Samaneh Farashi et al. Genes
- PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
- (2019) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations
- (2019) Catherine H. Marshall et al. EUROPEAN UROLOGY
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Benefits and limitations of genome-wide association studies
- (2019) Vivian Tam et al. NATURE REVIEWS GENETICS
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A genome‐wide association study of prostate cancer in Latinos
- (2019) Zhaohui Du et al. INTERNATIONAL JOURNAL OF CANCER
- Association analyses identify 31 new risk loci for colorectal cancer susceptibility
- (2019) Philip J. Law et al. Nature Communications
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
- (2019) Elizabeth C. Page et al. EUROPEAN UROLOGY
- 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population
- (2019) Ryo Takata et al. Nature Communications
- Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis
- (2018) I N Benke et al. ANNALS OF ONCOLOGY
- Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
- (2018) Martina Mijuskovic et al. BRITISH JOURNAL OF CANCER
- A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
- (2018) Sarah Benafif et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
- (2018) Dalia Kamel et al. CURRENT DRUG TARGETS
- Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
- (2018) Emmanuel S. Antonarakis et al. EUROPEAN UROLOGY
- The impact of variant classification on the clinical management of hereditary cancer syndromes
- (2018) Scott A. Turner et al. GENETICS IN MEDICINE
- Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Noel Clarke et al. LANCET ONCOLOGY
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
- (2018) Fredrick R. Schumacher et al. NATURE GENETICS
- Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer
- (2018) Pedro Isaacsson Velho et al. PROSTATE
- Principles of Genetic Counseling in the Era of Next-Generation Sequencing
- (2018) Mina Yang et al. Annals of Laboratory Medicine
- The Epidemiology of Prostate Cancer
- (2018) Claire H. Pernar et al. Cold Spring Harbor Perspectives in Medicine
- Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer
- (2018) Paula Paulo et al. PLoS Genetics
- PD-1/PD-L1 pathway inhibitors in advanced prostate cancer
- (2018) Pedro Isaacsson Velho et al. Expert Review of Clinical Pharmacology
- Malignant Abnormalities in Male BRCA Mutation Carriers
- (2018) Roy Mano et al. JAMA Oncology
- Mechanisms of PARP inhibitor sensitivity and resistance
- (2018) Alan D. D’Andrea DNA REPAIR
- Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing
- (2018) Jacqueline Mersch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer Risks for PMS2-Associated Lynch Syndrome
- (2018) Sanne W. ten Broeke et al. JOURNAL OF CLINICAL ONCOLOGY
- High speed of fork progression induces DNA replication stress and genomic instability
- (2018) Apolinar Maya-Mendoza et al. NATURE
- 793PDPreliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations
- (2018) W Abida et al. ANNALS OF ONCOLOGY
- Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
- (2018) Zafeiris Zafeiriou et al. EUROPEAN UROLOGY
- Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations
- (2018) Emmanuel S. Antonarakis et al. EUROPEAN UROLOGY
- Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing
- (2018) Veda N. Giri et al. PROSTATE
- Germline variation at 8q24 and prostate cancer risk in men of European ancestry
- (2018) Marco Matejcic et al. Nature Communications
- A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases
- (2018) Serena Oliveri et al. Frontiers in Genetics
- Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
- (2018) Fatima Karzai et al. Journal for ImmunoTherapy of Cancer
- Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
- (2017) Y.C. Lee et al. EUROPEAN JOURNAL OF CANCER
- Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
- (2017) Rong Na et al. EUROPEAN UROLOGY
- Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes
- (2017) Paula Paulo et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
- (2017) Roger L Milne et al. NATURE GENETICS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence
- (2017) Brian F. Dinerman et al. UROLOGY
- Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2
- (2017) Sigurdis Haraldsdottir et al. Nature Communications
- The 2010 NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer
- (2017) James L. Mohler Journal of the National Comprehensive Cancer Network
- Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications
- (2016) Carrie Snyder Familial Cancer
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
- (2016) Sarah S. Kalia et al. GENETICS IN MEDICINE
- Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
- (2016) Lorelei A. Mucci et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study
- (2016) Charlotte Näslund-Koch et al. JOURNAL OF CLINICAL ONCOLOGY
- PALB2,CHEK2andATMrare variants and cancer risk: data from COGS
- (2016) Melissa C Southey et al. JOURNAL OF MEDICAL GENETICS
- ATM Mutations in Cancer: Therapeutic Implications
- (2016) M. Choi et al. MOLECULAR CANCER THERAPEUTICS
- Gene regulatory mechanisms underpinning prostate cancer susceptibility
- (2016) Thomas Whitington et al. NATURE GENETICS
- Counselling framework for moderate-penetrance cancer-susceptibility mutations
- (2016) Nadine Tung et al. Nature Reviews Clinical Oncology
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population
- (2016) Jacek Marzec et al. Oncotarget
- Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer
- (2016) Hong-Jian Jin et al. Oncotarget
- Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer
- (2016) Julie N. Graff et al. Oncotarget
- Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing
- (2016) Christine Stanislaw et al. Cancer Biology & Medicine
- Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes
- (2015) Z. Kote-Jarai et al. ANNALS OF ONCOLOGY
- PARP inhibitors in the management of breast cancer: current data and future prospects
- (2015) Luca Livraghi et al. BMC Medicine
- The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies
- (2015) J. L. Beebe-Dimmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genome-Wide Association Study of Prostate Cancer-Specific Survival
- (2015) R. Szulkin et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Contribution of shared environmental factors to familial aggregation of common cancers
- (2015) Kristina Sundquist et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis
- (2015) Gail P. Risbridger et al. EUROPEAN UROLOGY
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
- (2015) Elena Castro et al. EUROPEAN UROLOGY
- The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer
- (2015) Sofia Maia et al. Familial Cancer
- Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites
- (2015) Huajie Bu et al. HUMAN MUTATION
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting Incidental Findings in Genomic Scale Clinical Sequencing—A Clinical Laboratory Perspective
- (2015) Madhuri Hegde et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer
- (2015) Meilin Wang et al. Nature Communications
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients
- (2015) Sofia Maia et al. PLoS One
- The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer
- (2014) M R Akbari et al. BRITISH JOURNAL OF CANCER
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
- (2014) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- Cancers associated withBRCA1andBRCA2mutations other than breast and ovarian
- (2014) Jacqueline Mersch et al. CANCER
- Risk of Prostate Cancer in Lynch Syndrome: A Systematic Review and Meta-analysis
- (2014) S. Ryan et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry
- (2014) Christophe Rosty et al. Familial Cancer
- Prostate cancer incidence in males with Lynch syndrome
- (2014) Sigurdis Haraldsdottir et al. GENETICS IN MEDICINE
- Generalizability of established prostate cancer risk variants in men of African ancestry
- (2014) Ying Han et al. INTERNATIONAL JOURNAL OF CANCER
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
- (2014) Ali Amin Al Olama et al. NATURE GENETICS
- A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
- (2014) Qilai Huang et al. NATURE GENETICS
- Prostate cancer in young men: an important clinical entity
- (2014) Claudia A. Salinas et al. Nature Reviews Urology
- Prostate cancer and the influence of dietary factors and supplements: a systematic review
- (2014) Dalvinder Mandair et al. Nutrition & Metabolism
- HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
- (2013) V. H. Laitinen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial
- (2013) Z. Chen et al. CARCINOGENESIS
- Germline Homeobox B13 (HOXB13) G84E Mutation and Prostate Cancer Risk in European Descendants: A Meta-analysis of 24 213 Cases and 73 631 Controls
- (2013) Zhiqun Shang et al. EUROPEAN UROLOGY
- Incorporating genomics into breast and prostate cancer screening: assessing the implications
- (2013) Susmita Chowdhury et al. GENETICS IN MEDICINE
- Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression
- (2013) Zsofia Kote-Jarai et al. HUMAN MOLECULAR GENETICS
- Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
- (2013) Susan M. Domchek et al. JOURNAL OF CLINICAL ONCOLOGY
- Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome
- (2013) Victoria M. Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence of the HOXB13 G84E Mutation Among Unaffected Men with a Family History of Prostate Cancer
- (2013) Elizabeth Handorf et al. Journal of Genetic Counseling
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
- (2013) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Hereditary breast and ovarian cancer susceptibility genes (Review)
- (2013) HIROSHI KOBAYASHI et al. ONCOLOGY REPORTS
- The advantages and limitations of trait analysis with GWAS: a review
- (2013) Arthur Korte et al. Plant Methods
- The role of BRCA1 and BRCA2 in prostate cancer
- (2012) Elena Castro et al. ASIAN JOURNAL OF ANDROLOGY
- An inherited NBN mutation is associated with poor prognosis prostate cancer
- (2012) C Cybulski et al. BRITISH JOURNAL OF CANCER
- Germline BRCA1 mutations increase prostate cancer risk
- (2012) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- Evaluating Genetic Risk for Prostate Cancer among Japanese and Latinos
- (2012) I. Cheng et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer
- (2012) J. P. Breyer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
- (2012) Robert Karlsson et al. EUROPEAN UROLOGY
- EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients
- (2012) Marjolijn J. L. Ligtenberg et al. Familial Cancer
- Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry
- (2012) Mala Pande et al. Familial Cancer
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)
- (2012) Jianfeng Xu et al. HUMAN GENETICS
- Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
- (2012) Christoph Engel et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel Germline mutation inHOXB13is associated with prostate cancer risk in Chinese men
- (2012) Xiaoling Lin et al. PROSTATE
- Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer
- (2011) A. Brandt et al. ANNALS OF ONCOLOGY
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families
- (2011) Heather Thorne et al. Cancer Prevention Research
- Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility
- (2011) He-ping Xiang et al. EUROPEAN JOURNAL OF CANCER
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
- (2011) A. Moran et al. Familial Cancer
- A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact
- (2011) Robert J. MacInnis et al. GENETIC EPIDEMIOLOGY
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
- (2011) Valérie Bonadona JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
- (2011) Cezary Cybulski et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Loci on Chromosome 8q24 are Associated With Prostate Cancer in Northern Chinese Men
- (2011) Ming Liu et al. JOURNAL OF UROLOGY
- Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21
- (2011) Christopher A Haiman et al. NATURE GENETICS
- Meat Consumption, Cooking Practices, Meat Mutagens, and Risk of Prostate Cancer
- (2011) Esther M. John et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Early onset prostate cancer has a significant genetic component
- (2011) Ethan M. Lange et al. PROSTATE
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
- (2010) Ryo Takata et al. NATURE GENETICS
- A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
- (2009) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer
- (2009) E. M. Grindedal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
- (2009) Feng Zhang et al. CURRENT BIOLOGY
- The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens
- (2009) John D. Norris et al. MOLECULAR CELL
- Age at Diagnosis and Age at Death in Familial Prostate Cancer
- (2009) A. Brandt et al. ONCOLOGIST
- Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
- (2009) L. A. Hindorff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
- (2009) S. Jones et al. SCIENCE
- Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa
- (2009) Folakemi T Odedina et al. Infectious Agents and Cancer
- Lifestyle behaviors, obesity, and perceived health among men with and without a diagnosis of prostate cancer: A population-based, cross-sectional study
- (2008) Laura Q Rogers et al. BMC PUBLIC HEALTH
- The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome
- (2008) Patrice Watson et al. INTERNATIONAL JOURNAL OF CANCER
- PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility
- (2008) C. Godon et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now